You've just added:

Home / News

Articles

April 12, 2023

UMass Chan Scientists Deliver siRNA Therapy to Lung

Harrington Scholar Dr. Khvorova and research team have developed a technology to deliver gene therapy directly to lung tissue through intranasal administration, a development that could potentially create a new class of treatments for lung disease. Continue Reading

February 23, 2023

Discovery of Potential New Way to Prevent Vision Loss

UVA Health School of Medicine scientists have discovered an unknown contributor to harmful blood vessel growth in the eye that could lead to new treatments for blinding macular degeneration and other common causes of vision loss. Continue Reading

February 14, 2023

Broad ALS Targets Show Signs of Success in Treating Genetic and Sporadic Forms

Studies published from researchers at the biotech startup AcuraStem and the University of Southern California validated two potential drug targets in animal models of both genetic and sporadic ALS, paving the way for broad treatments. Continue Reading

February 10, 2023

Potential Therapeutic Target for Blood Cancers Discovered

Investigators discovered that a specific complex drives cell proliferation in different forms of blood cancers called mutated myeloproliferative neoplasms (MPNs), suggesting the complex could serve as an ideal therapeutic target for blood cancer. Continue Reading

February 08, 2023

Single Drug Injection Wards off COVID-19 Hospitalizations, in Stanford Medicine-Led Trial

In an international, multicenter, pivotal Phase 3 trial, a single under-the-skin injection of a biological drug given to patients within seven days of the onset of COVID-19 symptoms cut the likelihood they needed to be hospitalized in half. Continue Reading

November 22, 2022

ASU Researchers Developing Pioneering Drug to Treat Alzheimer's Disease in Down Syndrome Patients

Travis Dunckley, PhD, University of Arizona, 2016 ADDF-Harrington Scholar and team have developed a candidate drug they hope may successfully block the development or advancement of Alzheimer’s disease in Down syndrome patients. Continue Reading

October 19, 2022

PIC Closes $35M Series A to Advance Novel Breast Cancer Therapeutic

PIC Therapeutics has closed a $35 million Series A financing round centered around the advancement of its lead asset, a novel therapeutic for advanced metastatic breast cancer. Continue Reading

August 18, 2022

Harrington Scholar Developing a Universal Therapeutic that can Prevent and Treat All Strains of Influenza A

Harrington Scholar developing a universal treatment to prevent and treat influenza A. Continue Reading

August 15, 2022

Novel Oral SIK Inhibitors for Musculoskeletal Diseases Licensed to Radius Health

Licensing IP for SIK Inhibitors to Radius Health Continue Reading

August 09, 2022

A Prescription for Exercise: Scientists Want to Help You Find the Best Workout for Your Brain

Development of an exercise wearable to help personalize exercise and minimize the risks of dementia. Continue Reading

We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.